Skin boosters

Not every injectable is designed to change the shape of your face.

Sometimes the goal is much more subtle: to improve the skin itself.

SkinBoosters are a specialised form of hyaluronic acid treatment in which tiny amounts of carefully selected hyaluronic acid are placed within the skin, rather than being used to create structural volume.

The objective is not bigger cheeks, fuller lips or a sharper jawline.

It is better skin.

Think radiance, luminosity, hydration, smoothness and that elusive healthy glow.

And importantly, this is not simply a fancy moisturiser delivered by needle. There is fascinating science behind what happens to the skin at a cellular and microscopic level.

What is a SkinBooster?

Hyaluronic acid is a naturally occurring molecule within our skin with a remarkable ability to attract and retain water.

With ageing, environmental exposure and hormonal changes, the skin's ability to maintain hydration and a healthy extracellular matrix gradually declines. This contributes to changes in texture, fine lines, elasticity, firmness and luminosity.

SkinBoosters use specially formulated hyaluronic acid in very small quantities and very small droplets, placed precisely into the dermis.

The treatment is therefore fundamentally different from a traditional volumising filler.

Traditional filler:

We place product where we want to create volume, projection, support or shape.

SkinBooster:

We place tiny amounts of product within the skin to influence hydration and skin quality.

The result should not be a different face.

It should be your face with better-quality skin.

The science is actually fascinating

One of the reasons I particularly like this treatment is that the science goes beyond simply putting hyaluronic acid into the skin and hoping it looks better.

Research into intradermal hyaluronic acid microdroplets has demonstrated measurable changes in the biology of treated skin.

One particularly interesting player is Aquaporin-3, or AQP3.

Aquaporins are proteins within cell membranes that help regulate the movement of water and glycerol into and out of cells. AQP3 is particularly important in the epidermis, where hydration, keratinocyte function and the skin barrier all depend on effective water and glycerol transport.

Studies of intradermal hyaluronic acid treatment have demonstrated increased AQP3 expression in treated skin, alongside measurable improvements in hydration. (PubMed Central (PMC))

In other words, the story is potentially more interesting than:

"We injected something that holds water."

There is evidence that the skin itself responds.

Hydration from within

Clinical studies of hyaluronic acid microdroplet treatment have demonstrated increased skin hydration and significant improvements in cheek skin smoothness.

In the pivotal clinical study of VYC-12L, approximately 58% of treated participants demonstrated at least a one-grade improvement in cheek smoothness at one month, with approximately 56% still meeting that criterion at six months.

Patients also reported improvements in how glowing, hydrated, refreshed and healthy their skin looked.

That distinction matters.

We are not necessarily trying to make the skin look "filled".

We are trying to make it look well hydrated, smoother, fresher and healthier.

What about collagen and elasticity?

This is where the science gets particularly interesting.

In a small prospective human study, researchers took biopsies of treated and untreated skin following intradermal VYC-12L treatment.

They found increased AQP3 expression, changes in the extracellular matrix and a qualitative increase in papillary dermal collagen I at three months. Treated skin also demonstrated greater firmness and resistance to deformation.

Earlier laboratory work using human skin explants demonstrated increases in collagen density and fibrillin-1 expression following treatment, together with increased AQP3 and glycosaminoglycans.

This is important because fibrillin is part of the elastic fibre network of the skin.

I would therefore describe the science as:

"supporting hydration, extracellular matrix health, collagen and components of the skin's elastic fibre network, rather than simply claiming that the treatment "stimulates elastin"."

The biology is more nuanced than the marketing version.

And that is exactly what makes it interesting.

So what does it actually look like?

This is not usually a dramatic before-and-after transformation.

There should not be a sudden change in facial proportions.

Instead, the improvements can be wonderfully subtle:

Radiance

Skin reflects light more beautifully.

Luminosity

The complexion can appear fresher and more vibrant.

Hydration

The skin feels less dry and looks more supple.

Texture

Fine lines and surface irregularity can become less noticeable.

Smoothness

The skin can look more even and refined.

Healthy glow

That difficult-to-define quality that makes skin look well cared for and well hydrated.

The aim is not for somebody to say:

"What have you had done?"

It is for them to think:

"You look really well."

Who is this for?

Younger patients beginning their injectable journey

You may not need volume.

You may not need lifting.

You may not need significant structural correction.

Sometimes the most appropriate first injectable treatment is simply an opportunity to improve skin quality.

It can be a beautiful way to introduce younger patients to aesthetic medicine without immediately embarking on a volumising treatment journey.

Patients who have already had a lot of filler

This is one of my most important applications.

There comes a point where adding more volume is not necessarily the answer.

If you have already had substantial filler over the years and are concerned about looking over-filled, we can change the conversation.

Instead of asking:

"Where can we put more filler?"

we can ask:

"How can we improve the quality of the skin we already have?"

SkinBoosters allow us to work on hydration, texture, smoothness and luminosity without intentionally changing the underlying shape of the face.

Sometimes better skin is more valuable than more filler.

Patients who are nervous about fillers

Perhaps you have always been curious about injectables but the idea of changing your face makes you nervous.

You want to understand what all the fuss is about, but you are not ready for cheeks, lips, chin or jawline enhancement.

A SkinBooster can be an interesting place to start.

It is still an injectable treatment, and it still requires medical expertise, but the intention is very different.

You are not trying to create a new face.

You are exploring what happens when you improve the quality of the skin you already have.

The science-curious patient

And then there is my favourite category:

The person who wants to know what is actually happening biologically.

If you love the idea of treatments that interact with the biology of your own tissues rather than simply creating an immediate visual effect, SkinBoosters are fascinating.

The research into hyaluronic acid microdroplet treatments has demonstrated changes in hydration, AQP3 expression, extracellular matrix markers, collagen and skin mechanical properties.

That means we are beginning to understand not only what the skin looks like afterwards, but also some of what happens underneath the surface.

Where can SkinBoosters be used?

SkinBoosters can be used in areas where improving skin quality rather than adding significant volume is the goal.

Common treatment areas include:

What happens during the treatment?

This is a precision treatment.

A topical anaesthetic is applied beforehand to improve comfort.

The skin is then treated with multiple microscopic injections, placing very small amounts of product into the appropriate layer of the skin.

The technique is deliberately different from traditional filler placement.

Placement matters.

The product needs to be delivered at the correct depth, in the correct quantity and in an appropriate distribution pattern.

This is not a treatment where more product automatically means better results.

In fact, with SkinBoosters, precision is part of the treatment.

Quality matters

Not all hyaluronic acid products are created for the same purpose.

Different HA formulations have different molecular characteristics, concentrations, degrees of cross-linking, rheological properties and tissue behaviours.

A product designed to create structural volume is not necessarily the right product to distribute as microscopic intradermal droplets.

For this reason, product selection matters enormously.

So does injection technique.

So does anatomy.

And so does understanding what you are actually trying to achieve.

This is why SkinBoosters should be regarded as a medical aesthetic treatment rather than simply another form of skincare.

What SkinBoosters don't do

SkinBoosters are not a replacement for traditional dermal fillers.

They are not designed to:

• Add significant facial volume
• Create cheek projection
• Build a jawline
• Increase chin projection
• Replace lost structural support
• Lift severely sagging tissue
• Correct significant facial asymmetry

If the problem is volume loss or structural change, traditional filler may be more appropriate.

If the problem is skin quality, a SkinBooster may be the better conversation.

And sometimes the best treatment is a combination of both, carefully planned over time.

The philosophy

As aesthetic medicine evolves, I think we are becoming much more interested in skin quality.

Not simply: More.

But: Better.

Not necessarily changing the architecture of the face, but improving the tissue that covers it.

Not chasing perfection, but improving hydration, texture, luminosity and the biological quality of the skin.

Because beautiful skin does not need to look filled.

It needs to look healthy.

Radiance.

Luminosity.

Healthy glowing skin.

Sometimes the most sophisticated aesthetic treatment is the one nobody can quite put their finger on.

Individual results vary. SkinBooster treatment is a medical procedure and suitability, product selection, treatment areas and expected results are determined following individual consultation.

Risks, who should wait and aftercare